Chongqing's High-Tech Pharmaceutical Companies Make Inroads into International Markets, Including the U.S. | Exclusive

Chongqing - You Hongtao, chairman of Chongqing Pharscin Pharmaceutical Co., Ltd., stated that Pharscin Pharma is "committed to international cutting-edge science and technology, transforming from ‘Made in China’ to ‘Created in China.’"

Chongqing Pharscin Pharmaceutical Co., Ltd. is a significant national high-tech enterprise integrating drug research and development, production, and sales. The company has its headquarters and research center in Chongqing's Liangjiang New Area and its production center in Rongchang High-tech Zone.

You Hongtao, chairman of Chongqing Pharscin Pharmaceutical Co., Ltd. (Photo/You Hongtao)

NYC subsidiary introduced an anxiolytic for anxiety disorders

The first High-Quality Development Cooperation Summit of the Private Economy in Chengdu-Chongqing Economic Circle took place in Rongchang District, Chongqing, on March 31, with Sichuan and Chongqing set to alternate hosting the summit every year to create a platform for private economic cooperation and exchanges.

You Hongtao said, "We will leverage the close cooperation between Chengdu and Chongqing to enhance integration with advanced international technology, introduce top-notch medical technology, and provide safer and higher-quality drugs."

Pharscin Pharma, a key national high-tech enterprise focusing on research and development, production, and sales of drugs, has its headquarters and research center in Chongqing's Liangjiang New Area, with its production center located in Rongchang High-tech Zone. The company has established a U.S. subsidiary in New York City, Pharscin US Inc., to serve as a bridge between the Chengdu-Chongqing region and the world's advanced medical technology, introducing the latest first-class drugs and advanced medical research technology.

According to You, Pharscin Pharma has obtained ownership of the first buspirone hydrochloride tablets, a globally recommended anxiolytic used for the treatment of generalized anxiety disorder and other anxiety disorders, in the U.S. Once the production site is approved by the Food and Drug Administration (FDA) for production, the product will be manufactured, helping the company expand into international markets, including the U.S.

"Our manufacturing site in Chongqing is preparing for the upcoming Current Good Manufacture Practices (CGMP) inspections by the FDA in May," You said. "Once we pass the inspection, our factory will integrate into the international pharmaceutical production system, enabling us to comply with international standards and expand our operations abroad."

Build a stage for the development of the private economy

According to this year's government work report on March 5, China will encourage and support the private sector and private businesses in growing and expanding, as well as support micro, small, and medium-sized enterprises and self-employed individuals in business development.

Pharscin Pharma, a private company that primarily distributes its products in the domestic market, contributes to the construction of the Chengdu-Chongqing economic circle and promotes more cooperation and exchanges. The company has established a world-class pharmaceutical production platform that integrates the Internet, big data, and artificial intelligence in Rongchang High-tech Zone.

With 22 production lines, including tablets, soft capsules, freeze-dried powder injections, API synthesis, and pre-processing and extraction of Chinese traditional medicines, Pharscin Pharma has built a fully automatic intelligent Chinese medicine traditional extraction production line and a modern warehousing and logistics center.

"Because Chengdu has a relatively cutting-edge scientific research and education environment, Pharscin Pharma cooperated with West China Hospital of Sichuan University to establish Chengdu Origant Pharmaceutical Co., Ltd," said You.

Chengdu Origant Pharmaceutical Co., Ltd. is a new drug research and development company dedicated to small molecule-targeted innovative drugs. It mainly focuses on the screening of new oncology drug targets, drug candidate development, translational medical research, preclinical and clinical development, registration application, market access, and other work to promote the high-quality development of the biomedical industry in the two places.

"The construction of the Chengdu-Chongqing Economic Circle has promoted the development of the private economy, deepened the cooperation between the two cities, and provided a broader stage and more opportunities for the development of the private economy," added You.